biostudies-literatureUnknown39(12)Huang H<h4>Purpose</h4>Surgical excision is the standard treatment for pterygium. This study was conducted to evaluate the safety and efficacy of a novel technique using low-temperature plasma (LTP) for excision and hemostasis in pterygium surgery.<h4>Methods</h4>A prospective, comparative, and randomized clinical trial was conducted on 60 patients (60 eyes) undergoing pterygium excision with conjunctival autografts using fibrin glue. Patients were equally divided into the following 2 groups: a control group and a LTP group. Postoperative follow-up visits were scheduled on day 1, week 1, and months 1 and 3, and recurrence was evaluated at 1 year. Patients were examined for operative time, best corrected visual acuity, conjunctival autograft inflammation (CAI), graft stability (GS), pain, recurrenCornea1581-1587https://www.ebi.ac.uk/biostudies/studies/S-EPMC7647423biostudies-literatureEvaluation of the Safety and Efficacy of a Low-Temperature Plasma Surgical System for Pterygium.PMC7647423Wang MLi SWang BHuang HZhong JPeng LYuan JDeng YfalseEvaluation of the Safety and Efficacy of a Low-Temperature Plasma Surgical System for Pterygium.<h4>Purpose</h4>Surgical excision is the standard treatment for pterygium. This study was conducted to evaluate the safety and efficacy of a novel technique using low-temperature plasma (LTP) for excision and hemostasis in pterygium surgery.<h4>Methods</h4>A prospective, comparative, and randomized clinical trial was conducted on 60 patients (60 eyes) undergoing pterygium excision with conjunctival autografts using fibrin glue. Patients were equally divided into the following 2 groups: a control group and a LTP group. Postoperative follow-up visits were scheduled on day 1, week 1, and months 1 and 3, and recurrence was evaluated at 1 year. Patients were examined for operative time, best corrected visual acuity, conjunctival autograft inflammation (CAI), graft stability (GS), pain, recurren2020-01-01T00:00:00Z2020 Dec2025-04-04T22:27:02.243Z2020-11-19T16:13:10ZS-EPMC76474233317059010.1097/ICO.0000000000002487